Scheduled maintenance will begin on May 30th, 2025. Server will be temporarily unavailable — learn more.
current user: public

If you have questions about the server, please let us know.

Query: [S] KOG2422 Uncharacterized conserved protein, from VFDB

Results of FFAS03 search in VFDB
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .
# Score Template Links and tools%idFirst MSGRLLKKVLQEHEDSKLQKHHEEEEEEDEEESGARSSINPFDLLNDGDEDPEEIDDETIAEKKNEDADHQSSVADHVQPVSKNKSKKKKKKKNKESGSNVPKAEMTLDETLEALGLNANSKQDKVQETKPNADSSKKASSRFVLEIDSKYLNLENELRRTYGSKAMRSFESESGSQGGSSSRRGGRRGVHHITKTVLVSPKENWSRWDRSFSMEFLETKDGNNYFRYTHSSSYEQAQRAFQAAQAIHDLNGVASVLIHNPYHIESLITMADYFKFVGENDMAADSIGKCLYGLERAWHPMFTPFQGNCRLEFNHDENKLFFKTLFTHMRNMDRRGCHRSALEVCKLLLSLDTSNPVGALFCVDYFALRAEEYAWLEQFSEEYRNDNSLWLFPNFSYSLAIARVYLEKMEPTSSSEATPRDTSKQSSLDLMTQALKLHPTVLNKLVEKVPLKDQAWTKILKHSYFRSDESKIPSLDHLIKIYVERNYLIWRLPDVQKLLRSAADLVIESLEQDGTEAESWLCVRLEAFSSENNQYSHLSTHDFSDSMPTLPPDNLQNFVADPRMVGGEQMAEGGGRGQHQAPPPRPRDLANRSPLAVLIESILPWANFGDGEDEIAHDAHHQPDNNGLast
1 -165.000[S] KOG2422 Uncharacterized conserved protein  ali  100  1MSGRLLKKVLQEHEDSKLQKHHEEEEEEDEEESGARSSINPFDLLNDGDEDPEEIDDETIAEKKNEDADHQSSVADHVQPVSKNKSKKKKKKKNKESGSNVPKAEMTLDETLEALGLNANSKQDKVQETKPNADSSKKASSRFVLEIDSKYLNLENELRRTYGSKAMRSFESESGSQGGSSSRRGGRRGVHHITKTVLVSPKENWSRWDRSFSMEFLETKDGNNYFRYTHSSSYEQAQRAFQAAQAIHDLNGVASVLIHNPYHIESLITMADYFKFVGENDMAADSIGKCLYGLERAWHPMFTPFQGNCRLEFNHDENKLFFKTLFTHMRNMDRRGCHRSALEVCKLLLSLDTSNPVGALFCVDYFALRAEEYAWLEQFSEEYRNDNSLWLFPNFSYSLAIARVYLEKMEPTSSSEATPRDTSKQSSLDLMTQALKLHPTVLNKLVEKVPLKDQAWTKILKHSYFRSDESKIPSLDHLIKIYVERNYLIWRLPDVQKLLRSAADLVIESLEQDGTEAESWLCVRLEAFSSENNQYSHLSTHDFSDSMPTLPPDNLQNFVADPRMVGGEQMAEGGGRGQHQAPPPRPRDLANRSPLAVLIESILPWANFGDGEDEIAHDAHHQPDNNG 627
2 -29.800[R] KOG3807 Predicted membrane protein ST7 (tumor suppressor in humans)  ali follow..  11  104........................................................................................................................................HKHGTSFIEQVSVSHLQPLGGTESSISEPGSPSRNRENETSRQNLSECKVWRNPLNLFRGAEYRRYTWVTGKEPLTYYDMNLSAQDHQTFFTCDTDFLRPSDTVMQKAWRERNPPAAYQALELNNDCATAYVLLAE--EEATTIVDAERLFKQALKAGETIYRQSQQ-HQSPQHEAQLRRDTNVLVYIKRRLAMCARKLGRIREAVKIMRDLMKFPPLTMLNIHENLLESLLELQAYPDVQAVLAKYDDISL-PKSAAICYTAALLKTRTSEKFSPETASRRGLSTAEINAVEAIHRAVEFNPHVPKYLLEMKSLILPP-------------EHILKRGDSEAIAYAFFHLQHWRIEGALNLLQCTWEGTFHHVSVYPKKELPLFIHFTAGFCSSTAM-IAILTHQFPEIMGIFAKAVLG---------------------------------CPQPWASSGFEENTQDLKSEDLGLSS............ 543
3 -13.500[U] COG5010 Flp pilus assembly protein TadD, contains TPR repeats  ali follow..  11  64..........................................................................................................................................................................................................................................................ERIGQAYERNPKDREAGLNYANLLRMTGRNEQALAVMQQVAGAYGKAQAAAGQLEQALATISRAQTPDRPDWKLKSAEGAILDQLGRSAEARLRYREALDLKPNEPS-VLSNLGMSYLLTKDLRTAETYLKSAASQPDAG--SSVRQNLALAVGLQGRFQEAETIAGQELTSEQAEANVAYLRSVLS.............................................................................................................................................................................................. 257
4 -13.300[R] KOG1129 TPR repeat-containing protein  ali follow..  1.....MQCLSDSTYVDELENEDMGLAETFLDQNVIAPNARPGTSFARPKTSAKGVNPILRPTTNAGRPLSGVVRPQSSFKSGSMDQAVRTARTAKTARAVSSTSARNMRLGTASMAAGADGEFVNLARLNIDKYAADPQVNRQLFEYVFYYLNDIRVAHQIAGTASKAAGFEDYYWKNQ--------LAKCYLRLGMLQDATKQL---QSSLEQKKLIETFALLSKAYNRVDQPMAALKTYSAG------------LEVFPENVTMLTGMARVQEALGEYDESVKLYKRVLDA------------------------ESNNIEAIACVATTYYYGGKPELAMRYYRRILQMGVSSP--LFLNIGLCCMAAQQFDFALSSILRAQSTMTDDVAADVWYNIGQILVDIGDLVSAARSFRIAREGKIDEARSLYSSATSKNPYMFEGNYN.................................................................................................................................................................................... 413
5 -12.900[DO] KOG1155 Anaphase-promoting complex (APC), Cdc23 subunit  ali follow..  18LSDRCLYSAAKWAGEQLVGIEQDPSNFTPANTRFQRGSSSIRRRFSTNESISTPLPSVGFSQAATPLPEEDEAIDGDALYLAGEKRKEEEMIELEGPLGKSDAINRELVSLERDLSALRRTGAIDSFGKEKGNESLARASLVESVNSYPWNWSAWSELQSLCTSIEILNSLNLNNHGNAYQELRMHTESLAKYEYLQGIFSFSNYIQAQTAK--------------AQYSLREFDQVEIMFEELLRNDPSYLAHKVFLTDKYRPESCCIIGNYYSLKGQHEKAVMYFRRALKL------------------------NKKYLSAWTLMGHEYVEMKNTPAAIDAYRRAVDINPTD-YRAWYGLGQAYEMMGMPFYALHYFRKSIFFLPNDSRLWIAMAKCYQTEQLYMLEEAIKCYKRAVNCTDTEGIALNEEAAYYFEKDLERMDAEGLEGPN----------------MFEALVFLATHFKNHK----KFEEAEVYCTRLLDYSGPEKEKAKSLLRGIRMAQTGFPSMDLEHFP........................................................................................... 578
6 -12.400[G] COG2956 Predicted N-acetylglucosaminyl transferase  ali follow..  11  20............................................................................GRRSAQQNKQDEANRLSRDYVAGVNFLLSNQQDKAVDLF--------------------------LDMLKEDTGTVEAHLTLGNLF-DRAIRIHQTLMESASLTYEQRLLAIQQLGR---------------------------------DYMAAGLYDRAEDMFN------------QLTDETDFRIGALQQLLQIYQATSEWQKAIDVAERLVKLGKDKQRVEIDLDRAMTLLKKGAAADKNSARVSIMMGRVFMAKGEYAKAVESLQRVISQDRELVSETLEMLQTCYQQLGKTAEWAEFLQR-----AVEENTGADAELMLADIIEAR-------------DGSEAAQVYITRQLQRHPTM-RVFHKLMDYHLNEAEEGRAKESLMVLRDMVGEKVRSKPRYFTAYTLYWHCPSCRAW................................................................................................................................. 377
7 -12.100[R] KOG1124 FOG: TPR repeat  ali follow..  19TSSFSLSFLTPQIPENLCKSPTKIHIGTHGISGQSFLSHPTFSSKNTYLYAVVDRSSSGVFSPQKESANGEGEESNTEEGVLVVRRPLLENSDKESSEEEGKKYPARIDAGLSNIAKKMPIFEPERSESSSSSSAAAA------ARAQERPLAVNLDLSLYKAKVLARNFRYKDAEK--------------ILEKCIAYWPEDGRPYVALG----------------LSKQSKLAEARILYEKGCQSTQGENFDAATVADKKHVAAWHGWANLEIKQGNISKARNLLAKGLQTLALLEAKAGRYEQARYLFKQATICNSRSCASWLAWAQLEIQQERYPAARKLFEKAVQASPKNRF-AWHVWGVFEAGVGNVERGRKLLKIGHALNPRD--PVLLQSLGLLEYKHSSANLARALLRRAKEGNTTTARELYQRALSIDAAARRLFRSSLNINSQSYVTWMTWAQLEEDQGDTERAEEIRNLYFQQRTEVVDDASWVTGFLDIIDPALDTVKR................................................................................................................... 568
8 -11.900[D] KOG1126 DNA-binding cell division cycle control protein  ali follow..  10  221.SNSSISAFTKWFDRVDASELPGSEKERHQSLKLQSQSQTSKNLLAFNDAQKADSNNRDTSLKSHFVEPRTQALRPGARLTYKLREARSSKRGESTPQSFREEDNNKLREALNCFQSLPIEQQNTPFVFELVDYEKSEEVFQKLRDLSPSRVKDMEVFSTAL------------------WHLQKSVPLSYLAHETLETNPYSPESWCILA---------------CFSLQREHSQALKCINRA------------IQLDPTFEYAYTLQGHEHSANEEYEKSKTSFRKAIRV------------------------NVRHYNAWYGLGMVYLKTGRNDQADFHFQRAAEINPNNSV-LITCIGMIYERCKDYKKALDFYD...................................................................................................................................................................................................................................................... 557
9 -11.800[S] KOG4340 Uncharacterized conserved protein  ali follow..  15..TALVYRLIRDARYAEAVQLLGQ---HPELEQYRLYQAQALYKACLYPEATRVAFLLLDNPAYHSRVLRLQAAIKYSEGDLPGSRSLVEQLLSGEGGEESGGDNEQYEAACSKFSATLQASGYQPDLSYNLA---SSRQYASALKHIAEIIERGIRQHPELGVGMTTEGFDVRSVGNTLVLHQTALVEAFNLKAAIEYQ-LRNYEVAQETLTDMPPRAEEELDPVTL-HNQALMNMDARPTEGFEK-----LQFLLQQNPFPPETFGNLLLLYCKYEYFDLAADVLAENAHLTYKFLTPYLEAFIKLDGLAGMLTEQEKYIPVLMAQAKIYWNLENYPMVEKVFRKSVEFCNDHDVWKLNVAHVLFMQENKYKEAIGFYEPIVKKHYDNILNVSA-NLCVSYIMTSQNEEAEELMRKIEK---EEEQLSYDDPNRKMYHLCIVNLV------------------------------IGTLYCAKG----NYEFGISRVIKSLEPYNKKLGTDT-FLSLLENMSKHMIVIHDSVIQECVLGHCELYGTNIPAVI------------------EQPLEEERMHVGKNTVTDESRQLKALIYEIIGWNK.................... 628
10 -11.400[O] COG4235 Cytochrome c biogenesis factor  ali follow..  16  80..........................................................................................................................................................................................................................................................LGMRTQLQKNPGDIEGWIMLGRVGMALGNASIATDAYATAYRL---------------------DPKNSDAALGYAEALTRSSDPNDNRLGGELLRQLVRTDHSNI--VLSMYAFNAFEQQRFGEAVAAWEMMLKLLPANDTRRAVIERSIAQAMQHLSPQESK..................................................................................................................................................................................................................... 221
11 -11.200[DO] KOG1174 Anaphase-promoting complex (APC), subunit 7  ali follow..  1MNVRDMAAAGLHSNVRLLSSLLLTMSNNNPELFSPPQKYQLLVYHADSLFHDKEYRNAVSKYTMALQQKKALSKTSKVRPSTGNSASTPQSQCLPSEIEVKYKMLKQDKDAIAILDGIPSRQRTPKI-KKAGRERPSVTSYKEVLRQCPLALDAILGLLSLSGAEVASMTMNVIQTVPNLDWLSVWIKAYAFVHTGDNSRAISTICSLEKKSLLRDNVDLLGSLADLYFRAGDNKNSVLKFEQAQML-DLYLIKRLFNISDQHAEPWVVSGCHSFYSKRYSRALYLGAKAIQL------------------------NSNSVQALLLKGAALRNMGRVQEAIIHFREAIRLAPCR-LDCYEGLIECYLASNSIREAMVMANNVYKTLGANAQTLTLLATVCL----------------EDPVTQEKAKTLLDKALTQRPDYIKAVVKKAELEQKYEDGIALLRNALANQSDCVLHRILGDFLVAVN----EYQEAMDQYSIALS........................................................................................................................... 503
12 -11.100[S] COG3898 Uncharacterized membrane-bound protein  ali follow..  57ILWWLIRSLWNSPYTISRYFRVRRRDRGYQALST--------GMIAAGAGDGALARKKTKEAAKLIRSDQEPLIHLLEAQASLLEGDHEGARQKFESMLDDPEMRLLGLRGLYLEAERLGDRNAARHY------------AGRAAAVAPQLAWAAESTLEEL-------------------------------------TARGDWDGALKLVDAQKSTRQIERDAANRRRAVLLTAKAQSLADSDPNAARTAALEANKLQPDFAPAAVAAAAALFKQNDVRKGSKILETAWRAEPHP--------------------------EIAELYTHARPGDAVLDRLNRAKKLQEMKKNHAE-SSMTVARAALDAQDFSTARSEAEA-----AIRMDRREGAYLLLA------------DIEEAETGDQGKVRQLLSKAVRAPR............................................................................................................................................................................................ 394
13 -11.000[DO] KOG1173 Anaphase-promoting complex (APC), Cdc16 subunit  ali follow..  157MKGKVYEALDNRGMAMDFYVQALHKS------------FEALEALVQHEMLMAWEEFELMHHLPLAQQSSEADAKFILKLYESRLKKYYELISARNAEEMSPIVNPDILQFIKEFTARVQQSGSSDTQMPKVSAVKVPLTPSQFMSPAQKVLEDLKAPTFSLQTSLSKASSLIDASHRSMFDSSSRRRSRDHDTDTLIP------------IAECLDRVQRSTDLMKCFYDCDYKQCLKILNELLKVDP-YVAHKLVDRYPDKAISWYAVGCYYDMIGKSDPARRYLSKATFANENEHEQAMAAYFKATQL------MRGCHLPLLYIGVECGLTKNLELAEKFFLQAMNIAPLDVY-VLHELGVIKYEYEFFDGAATIFQC-AKSNNEEISSRWEINLGHSLRKVHKYEEALYNFQYALLGNLDPAIEAFHKSLALNR............................................................................................................................................................................................ 639
14 -10.700[NU] COG3063 Tfp pilus assembly protein PilF  ali follow..  16  45..................................................................................................................................................................................................................................EYMRGQDYRQATASIEDA------------LKSDPKNELAWLVRAEIYQYLKVNDKAQESFRQAL-----SIKPDSAEINNNYGWFLCGRLNR-FDKALLNKGICSAKQGQFGLAEAYLKRSLAAQPQFPP-AFKELARTKMLAGQLGDADYYFKKYQSRVEVLQADDLLLGWKIA----------------KALGNAQAAYEYEAQLQANFP............................................................................................................................................................................................ 241
15 -10.600[R] KOG2897 DNA-binding protein YL1 and related proteins  ali follow..  12  5RSRRNIAHLLNEEEEDDFYKTSYGGFQEDEEDKEYEQKDEEEDVVDSDFSIDENDEPVSDQEEAPEKKRKRGVVNTKAYKETKPAVKKETKATPALHKKRPGGGVTKVLDSGRKSIRTSTAIKTQATKIRLKELDDARKRKKKKVRVEDYMPTQEELL-----EEAKITEEENTKSLEKFQKMELEKKKSRPTKR................................................................................................................................................................................................................................................................................................................................................................................................................................................ 207
16 -10.500[R] KOG4264 Nucleo-cytoplasmic protein MLN51  ali follow..  11  1MADRRRQRASQDTEDEESGASGSDSGSLPSQRGGRTGALHLRRVESGGAKSAEESECESEDGIEGDAVLSDYESAEDSEGEEGEYSEEENSKVELKSEANDAVNSSTKEEKGEEKPDTKSTVTGERQSGDGQESTEPVENKVG----GPKHLDDDEDRKN--GLFFEHDLRGQTQEEEVRPKGRQRK----------LWKDEGRW-------------------------HDKFREDEQA---------PKSRQELIALYGYDI........................................................................................................................................................................................................................................................................................................................................................................... 244
17 -10.400[R] COG4785 Lipoprotein NlpI, contains TPR repeats  ali follow..  12  83..........................................................................................................................................................................................................................................................NDFSQALAIRPDMPEVFNYLGIYLTQAGNFDAAYEAFDSVLEL------------------------DPTYNYAHLNRGIALYYGGRDKLAQDDLLAFYQDDPNDPFRS-LWLYLAEQKLDEKQAKEVLKQHFEKSDKEQ------WGWNIVEFYLGNISEQTLMERLKADGDLDSATALFKLAVANNV............................................................................................................................................................................................ 265
18 -10.300[T] KOG4162 Predicted calmodulin-binding protein  ali follow..  11  1MANKNMRKVEALIESCRSEGKWHRVIELTDELKTGSPHNECLANFLVGEARLESYLEENALASDSNFGRAKSGLAEARRFLHLALGESGQKAGIALDAAKLCFACGEYEQSLDNFVKEQQTTKPSSKFKKAEKDTEMISCFERASDLGLLYLQEYDLVSGSSGSSNNSTAGSTLNVNASTVKTEKLQEAVERYRIMLNAIETRATQSLRLTLARQLAE--------KYAARQQFNQQEEVILLLLIAEALAVRDTVLSQSPEFRQARQLLTLATVRWGLVQLLNESFEKAL---------KFSFGEQH---------------VWRQYGLSLMAAEKHSHALRVLQESMKLTPSDPLPCLLASRLCYESLETVKQGLDYAQQALKREVKGLRPSLFVGIGHQQLAI------QSNLKSERDACHKLALDALERAVQFDG............................................................................................................................................................................................ 535
19 -10.100[A] KOG0495 HAT repeat protein  ali follow..  1MSNITAAVIANRNKKH-------GVPAPLGYVAGVGRGATGFTTRSDIGPARDANDVSDDRHAPPATKRKKKDEEEEEDEDLNDSNYDEFSGYSGSSKDPYDKDDEEADAIYDSIDKRMDEKRKEYRDRRLREDLERYRQERP--KIQQQFSDLKRSLASVTSEEWSTIPEVGDSRNRKQRNPRAEKSRNLGGESSSTLDPSSGLASMVPGVATPGMLTPTGDLDLRKIGQARNTLMNVKLSQVSDSVTGQTLKSVRETNPNHPPAWIASARLEEVTGKVQMARNLIMRGC---------EMNIQSEDLWLEAARLQPPDTAKAVIAWIKAADLESETKAKRRVFRKALEHIPNSVR-----LWKAAVELENPDDARILLSRAVECCNTS-----VLNKARENIPTDRQIWTTAAKLEEANGNIHMVEKIIDRSLTSLT............................................................................................................................................................................................ 467
20 -10.000[R] KOG1125 TPR repeat-containing protein  ali follow..  11  110.......DLLDLSEPVSQTQTKAKKSEPSSKTSSLKKKADGSDLISTDAEQRGQPLRVPETSSLDLDIQTQLEKWDDVKFHGDRNTKGHPMAERKSSSSRTGSKELLWSSEHRS--QPELSGGKSALNSESASELELVAPTQARLTKEHRWGSALLSRNHSLEEEFERAKAAVESDTEKMQAEWEEMARRNWISENQEAQNQVTISASEKGYYFHTENPFKDWPGAKRLKEGDLPVTILFMEAAILQ-DPGALQRCLELQPNNLKALMALAVSYTNTGHQQDACDALKNWI-----KQNPKYKYLVKSKKGSPGLTRRMSYLEAATGLGVLFHLSGEFNRAIDAFNAALTVRPEDRLGATLA------NGDRSEEAVEAYTR-----ALEIQPGFIYNLGISCINLGA----------------REAVSNFLTALSLQR............................................................................................................................................................................................ 573
21 -9.510[S] KOG2796 Uncharacterized conserved protein  ali follow..  11  1.....MLRFLGEKAAAKRQVLNADSVEQSFVGLKQLISCRNWRAAVDLCGRLLTAHGQGYGKSGLLTSHTTDSLQLWFVRLALLVKLGLFQNAEMEFEP------------FGNLDQPDLYYEYYPHVYPGRRGSMVPFSMRILHAELQQYLGNPQESLDRLHKVKTVCSKILANLEQGLAEDGGMSSVTQEGRQASIRLWRSRLGRVMYSMANCLLLMK------------DYVLAVDAYHSVIKYYPEQE-----------PQLLSGIGRISLQIGDIKTAEKYFQDVE------------------KVTQKLDGLQGKIMVLMNSAFLHLGQNNFAEAHRFFTEILRMDPRNAV-ANNNAAVCLLYLGKLKDSLRQLEAMVQQDPRHYLHESVLFNLTTMYELESSRSM------------QKKQALLEAVAGKEGDSFNTQCLKLA................................................................................................................................................................................. 379
22 -9.490[O] KOG0548 Molecular co-chaperone STI1  ali follow..  141TSDPSTRGFLQQPDFVNMMQEIQKNPSSLNLYLKDQRVMQSLGVLLNVKFRPPPPQGDEAEVPESDMGQSSSNEPEVEKKREPEPEPEPEVTEEKEKKERKEKAKKDFETAIQHYSTAIEIDDEDISYLTNRAANECIEDCNKAVERGRELRSDYKMVARALTRKGTALTKMAKCSKDYEPAIEAFQKALTEHRNPDTLKRLNDAERAKKEWEQKQYFDPKLGDEEDFFKEQKYPEAIKHYTEA------------IKRNPNDHKAYSNRAASYTKLGAMPEGLKDAEKCIEL------------------------DPTFSKGYSRKAAVQFFLKEYDNAMETYQAGLEHDPSNQ--LLDGVKRCVQQINKANRGDELKERQAKGMQDPEIQNILTDPVMRQVLSDLQENPSAAQKHMQNPMVMNKIQKLISAGIVQ............................................................................................................................................................................................. 570
23 -9.450[S] KOG3060 Uncharacterized conserved protein  ali follow..  16  48......................................................................................................................................................................................................................................NERHLILEQVIIAALDTARFDITKQLSLEFPGSLRVMKFKAMRYEALEQYDEADEVLDAIIAK------------------------DETNAAPRKRKIAILKARGRRLEAIKELNEYLKKFMSDQEA--HELCNMYLAEGEFGKAAFCMEE------LLHNPHIHQRLAEIRYTMGGVEN-------------ESARTYYSQALKLNPHNLRALYG.................................................................................................................................................................................... 229
24 -9.380[S] COG1729 Uncharacterized protein conserved in bacteria  ali follow..  68NGAG-ATGLEDQLRQMNGKIEELNFQILQMQEQMRKQQEDNEFRFQQLEGGAQGGQPPAPKKSDATTNTNTDVAAAPATQAPADAGAAPGGNQSAGGKTVEDVIVESPEGDPGKVIPGTGAPEKTFGSITVDKNGNVIDAG---------------------GNTQSTAPTQDAAPATKAPAKAGKSNGTIVAALPSTNDPEELY--------------------YQFILSGDYGTAEQGF------------RDHISRFPRD-DAHYWLGESLLGQQKYRDAAEVFLAAS----------------------DYPKAKKAPDMLLKLGVSLVGLKQHDVACATFSEVGKRYPDISSALKERVKQEKALAA................................................................................................................................................................................................................................................................ 369
25 -9.310[R] KOG1128 Uncharacterized conserved protein, contains TPR repeats  ali follow..  212KRTRFQQRDIAQLVLIHKDPSTTGTPLPPDSDIPQSLDMNDDTLLEQVAITEQGARVDGRTLNACQLSVHERCSPVLDTVIAARRYWSIQAAALLARAELERGRVRQVDRSCTQSELVVKLQQGVDDPVLIKDRLLRTSYILAS------GLTPFWQSSVLLAGLILEKLEMWDGVIDCYKQLGQMDKAETLIRRLIEQKPNDSMLHVYLGITRNLEYFTKAIELSDDRNARAHRSLGHLLLMDKKFEEAKHLRRSLELQPIQLGTWFNAGYCAWKLENFKESTQCYHRCVSL------------------------QPDHFEAWNNLSAAYIRHGQKPKAWKLLQEALKYNY-EHPNVWENYMLLSVDVGEFSQAIQAYHRLLDMNK----ADDEVLELIAQTLLRREAEISMDESEDKAQNEAENRKEKEEMIKLLARISANHQT.................................................................................................................................................................................... 657
26 -9.280[O] KOG3696 Aspartyl beta-hydroxylase  ali follow..  147.AKEQIQSLLHEM-VHAEHVEGEDLQQEDGPTGEPQQEDDEFLMATDVDDRFETLEPEVSHEETEHSYHVEETVSQDCNQDMEEMMSEQENPDSSEPVVEDERLHHDTDDVTYQVYEEQAVYEPLENEGIEITEVTAPPEDNPVEDSQVIVEEVSIFPVEEQQEVPPETNRKTDDPEQKAKVKKKKPKLLNKFDKTI---------------------------------KAELDAAEKLRKRGKIEEAVNAFKELVRKYPQSPRARYGKAQCEDDLAEKRRSNEVLRGAIETYQEV-------------ASLPDVPADLLKLSLKRRSDRQQFLGHMRGSLLTLQRLVQLFPNDTS-LKNDLGVGYLLIGDNDNAKK-----------------VYEEVLSVTPNDGFAKVHYGFILKAQNKIAESIPYLKEGIESGD............................................................................................................................................................................................ 519
27 -9.240[U] KOG3081 Vesicle coat complex COPI, epsilon subunit  ali follow..  22........................................................................................................................................................................................................................................AYQTAINNSEIANLSPE-LVISEIDESAATPLQAVKLLAMYLSTPQNKESTISSLKEWLADSTIGNNDTLRLIAGIIFMHEEDYNET--MDLYALNVQIFIKMHRAEYAEKQLRVMQQIDEDHTL-LASAWLNLAVGGSKIQEAYLIFEDFSEKYPMT--CLILNGKAVCCMQMGN----------------DEAETLLLEALNKDAKDPETLAN.................................................................................................................................................................................... 246
28 -9.230[R] COG4976 Predicted methyltransferase (contains TPR repeat)  ali follow..  14  2............................................................................................................................................................................................................................................................TFNQLSSGDLIADRRADYAKMLAEAGDAPGAAELMAQALEL------------------------APDWAAGWFRLADYEEKSGRIEAAVDALRNTLRLNPEDIFGASLKLALLTPEQPPSVYVERLFDDYAERFDHALVEKLGYSV.................................................................................................................................................................................................................................... 128

FFAS is supported by the NIH grant R01-GM087218-01
1 4 8 0 9 7   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Ye Y, Jaroszewski L, Li W, Godzik A. A segment alignment approach to protein comparison. Bioinformatics. 2003 Apr 12;19(6):742-9.